Stay updated on GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.

Latest updates to the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record for GVAX Pancreas Vaccine with nivolumab and SBRT is now available, including its completed status, eligibility criteria, study design, interventions, outcomes, and posted results information.SummaryDifference54%

- Check15 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0; the page still displays a 403 error.SummaryDifference0.2%

- Check22 days agoChange DetectedA notice announces an NIH-wide transition in terminology, saying agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2; the page remains a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error page with a minimal header and a Home link, indicating the study record is currently inaccessible. The substantive study content that was previously visible appears removed or blocked.SummaryDifference19%

Stay in the know with updates to GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.